Left atrial appendage-occluding devices for stroke prevention in patients with nonvalvular atrial fibrillation Yan BP, Kiernan TJ, Gonzales-Cruz I, Lam YY. Expert Review of Medical Devices 6(6):611-20. FI: 1.725 (Q3) Left atrial appendage exclusion using an amplatzer device Cruz-González I, Cubbedu RJ, Sánchez-Ledesma M, Cury RC, Coggins M, Maree AO, Palacios IF. International Journal of Cardiology 134(1):e1-3. FI: 3.469 (Q2) Anticoagulation with the direct thrombin inhibitor argatroban in patients presenting with acute coronary syndromes Yeh RW, Baron SJ, Healy JL, Pomerantsev E, McNulty IA, Cruz-González I, Jang IK. Catheterization and Cardiovascular 74(2):359-64. FI: 2.363 (Q2) In-hospital prognosis in non-ST-segment elevation acute coronary syndrome derived using a new risk score based on electrocardiographic parameters obtained at admission Jiménez-Candil J, González Matas JM, Cruz González I, Hernández Hernández J, Martín A, Pabón P, Martín F, Martín-Luengo C. Revista Española de Cardiología 63(7):851-5. FI: 2.746 (Q2) Influence of beta-blocker therapy on antitachycardia pacing effectiveness for monomorphic ventricular tachycardias occurring in implantable cardioverter-defibrillator patients: a dose-dependent effect Jiménez-Candil J, Hernández J, Martín A, Ruiz-Olgado M, Herrero J, Ledesma C, Moríñigo J, Martín-Luengo C. Europace 12(9):1231-8. FI: 1.871 (Q3) Relationship between the duration of the basal QRS complex and electrical therapies for ventricular tachycardias among ICD patients Jiménez-Candil J, Ruiz M, Herrero J, León V, Martín A, Moriñigo J, Ledesma C, Martín-Luengo C. Pacing and Clinical Electrophysiology 33(5):596-604. FI: 1.578 (Q3) Plasma cystatin C for prediction of 1-year cardiac events in Mediterranean patients with non-ST elevation acute coronary syndrome Taglieri N, Fernandez-Berges DJ, Koenig W, Consuegra-Sanchez L, Fernandez JM, Robles NR, Sánchez PL, Beiras AC, Orbe PM, Kaski JC. SIESTA Investigators. Atherosclerosis 209(1):300-5. FI: 4.522 (Q1) The role of inmature platelet fraction in acute coronary syndrome González-Porras JR, Martín-Herrero F, González-López TJ, Olazabal J, Díez-Campelo M, Pabón P, Alberca I, San Miguel JF. Thrombosis and Haemostasis 103(1):247-9. FI: 4.451 (Q1) Hyperglycemia on admission predicts larger infarct size in patients undergoing percutaneous coronary intervention for acute ST-segment elevation myocardial infarction Cruz-González I, Chia S, Raffel OC, Sánchez-Ledesma M, Senatore F, Wackers FJ, Nathan DM, Jang IK. Diabetes Research and Clinical Practice 88(1):97-102. FI: 2.160 (Q3) Left atrial appendage exclusion: State-of-the-art Cruz-González I, Yan BP, Lam YY. Catheterization and Cardiovascular 75(5):806-13. FI: 2.363 (Q2)
|
